Legacies of Leprosy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A History of Leprosy and Coercion in Hawai’I
THE PURSE SEINE AND EURYDICE: A HISTORY OF LEPROSY AND COERCION IN HAWAI’I A THESIS SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAIʻI AT MĀNOA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS IN ANTHROPOLOGY DECEMBER 2012 By David James Ritter Thesis Committee: Chairperson Eirik Saethre Geoffrey White Noelani Arista Keywords: Leprosy, Capitalism, Hansen’s Disease, Hawaiʻi, Molokaʻi, Kalaupapa, Political Economy, Medical Anthropology Acknowledgements I would like to extend my sincere gratitude to a number of individuals without whom this research would not have been possible. First, I would like to thank each of my committee members- Eirik Saethre, Geoff White, and Noelani Arista- for consistently finding time and energy to commit to my project. I would like to thank the staff and curators of the Asia Pacific collection at the Hamilton Library for their expertise University of Hawai`i at Mānoa. I would also like to thank my friend and office mate Aashish Hemrajani for consistently providing thought provoking conversation and excellent reading suggestions, both of which have in no small way influenced this thesis. Finally, I would like to extend my greatest gratitude to my parents, whose investment in me over the course this thesis project is nothing short of extraordinary. ii Abstract In 1865, the Hawai`i Board of Health adopted quarantine as the primary means to arrest the spread of leprosy in the Kingdom of Hawai`i. In Practice, preventing infection entailed the dramatic expansion of medical authority during the 19th century and included the establishment of state surveillance networks, the condemnation by physicians of a number of Hawaiian practices thought to spread disease, and the forced internment of mainly culturally Hawaiian individuals. -
Evidence for Mycobacterium Leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India
Am. J. Trop. Med. Hyg., 102(3), 2020, pp. 547–552 doi:10.4269/ajtmh.19-0390 Copyright © 2020 by The American Society of Tropical Medicine and Hygiene Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India Niranjan Prakash Mahajan,1 Mallika Lavania,2 Itu Singh,2 Saraswati Nashi,1 Veeramani Preethish-Kumar,1 Seena Vengalil,1 Kiran Polavarapu,1 Chevula Pradeep-Chandra-Reddy,1 Muddasu Keerthipriya,1 Anita Mahadevan,3 Tagaduru Chickabasaviah Yasha,3 Bevinahalli Nanjegowda Nandeesh,3 Krishnamurthy Gnanakumar,3 Gareth J. Parry,4 Utpal Sengupta,2 and Atchayaram Nalini1* 1Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India; 2Stanley Browne Research Laboratory, TLM Community Hospital, New Delhi, India; 3Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India; 4Department of Neurology, St John’s Medical College, Bangalore, India Abstract. Resistance to anti-leprosy drugs is on the rise. Several studies have documented resistance to rifampicin, dapsone, and ofloxacin in patients with leprosy. We looked for point mutations within the folP1, rpoB, and gyrA gene regions of the Mycobacterium leprae genome predominantly in the neural form of leprosy. DNA samples from 77 nerve tissue samples were polymerase chain reaction (PCR)-amplified for MlepraeDNA and sequenced for drug resistance–determining regions of genes rpoB, folP1, and gyrA. The mean age at presentation and onset was 38.2 ±13.4 (range 14–71) years and 34.9 ± 12.6 years (range 10–63) years, respectively. The majority had borderline tuberculoid leprosy (53 [68.8%]). Mutations associated with resistance were identified in 6/77 (7.8%) specimens. -
Chapter 3 Bacterial and Viral Infections
GBB03 10/4/06 12:20 PM Page 19 Chapter 3 Bacterial and viral infections A mighty creature is the germ gain entry into the skin via minor abrasions, or fis- Though smaller than the pachyderm sures between the toes associated with tinea pedis, His customary dwelling place and leg ulcers provide a portal of entry in many Is deep within the human race cases. A frequent predisposing factor is oedema of His childish pride he often pleases the legs, and cellulitis is a common condition in By giving people strange diseases elderly people, who often suffer from leg oedema Do you, my poppet, feel infirm? of cardiac, venous or lymphatic origin. You probably contain a germ The affected area becomes red, hot and swollen (Ogden Nash, The Germ) (Fig. 3.1), and blister formation and areas of skin necrosis may occur. The patient is pyrexial and feels unwell. Rigors may occur and, in elderly Bacterial infections people, a toxic confusional state. In presumed streptococcal cellulitis, penicillin is Streptococcal infection the treatment of choice, initially given as ben- zylpenicillin intravenously. If the leg is affected, Cellulitis bed rest is an important aspect of treatment. Where Cellulitis is a bacterial infection of subcutaneous there is extensive tissue necrosis, surgical debride- tissues that, in immunologically normal individu- ment may be necessary. als, is usually caused by Streptococcus pyogenes. A particularly severe, deep form of cellulitis, in- ‘Erysipelas’ is a term applied to superficial volving fascia and muscles, is known as ‘necrotiz- streptococcal cellulitis that has a well-demarcated ing fasciitis’. This disorder achieved notoriety a few edge. -
Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting As
Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting as Chronic Ulcers with Vasculitis: A Case Report and Discussion Anny Xiao, DO,* Erin Lowe, DO,** Richard Miller, DO, FAOCD*** *Traditional Rotating Intern, PGY-1, Largo Medical Center, Largo, FL **Dermatology Resident, PGY-2, Largo Medical Center, Largo, FL ***Program Director, Dermatology Residency, Largo Medical Center, Largo, FL Disclosures: None Correspondence: Anny Xiao, DO; Largo Medical Center, Graduate Medical Education, 201 14th St. SW, Largo, FL 33770; 510-684-4190; [email protected] Abstract Leprosy is a rare, chronic, granulomatous infectious disease with cutaneous and neurologic sequelae. It can be a challenging differential diagnosis in dermatology practice due to several overlapping features with rheumatologic disorders. Patients with leprosy can develop reactive states as a result of immune complex-mediated inflammatory processes, leading to the appearance of additional cutaneous lesions that may further complicate the clinical picture. We describe a case of a woman presenting with a long history of a recurrent bullous rash with chronic ulcers, with an evolution of vasculitic diagnoses, who was later determined to have lepromatous leprosy with reactive erythema nodosum leprosum (ENL). Introduction accompanied by an intense bullous purpuric rash on management of sepsis secondary to bacteremia, Leprosy is a slowly progressive disease caused by bilateral arms and face. For these complaints she was with lower-extremity cellulitis as the suspected infection with Mycobacterium leprae (M. leprae). seen in a Complex Medical Dermatology Clinic and source. A skin biopsy was taken from the left thigh, Spread continues at a steady rate in several endemic clinically diagnosed with cutaneous polyarteritis and histopathology showed epidermal ulceration countries, with more than 200,000 new cases nodosa. -
Historical Overview of Leprosy Control in Cuba
Review Article Historical Overview of Leprosy Control in Cuba Enrique Beldarraín-Chaple MD PhD ABSTRACT Program was established in 1962, implemented in 1963 and revised INTRODUCTION Leprosy, an infectious disease caused by Myco- fi ve times. In 1972, leper colonies were closed and treatment became bacterium leprae, affects the nervous system, skin, internal organs, ambulatory. In 1977, rifampicin was introduced. In 1988, the Program instituted controlled, decentralized, community-based multidrug treat- extremities and mucous membranes. Biological, social and environ- ment and established the criteria for considering a patient cured. In 2003, mental factors infl uence its occurrence and transmission. The fi rst it included actions aimed at early diagnosis and prophylactic treatment of effective treatments appeared in 1930 with the development of dap- contacts. Since 2008, it prioritizes actions directed toward the population sone, a sulfone. The main components of a control and elimination at risk, maintaining fi ve-year followup with dermatological and neurologi- strategy are early case detection and timely administration of multi- cal examination. Primary health care carries out diagnostic and treatment drug therapy. activities. The lowest leprosy incidence of 1.6 per 100,000 population was achieved in 2006. Since 2002, prevalence has remained steady at OBJECTIVES Review the history of leprosy control in Cuba, empha- 0.2 per 10,000 population. Leprosy ceased to be considered a public sizing particularly results of the National Leprosy Control Program, its health problem in Cuba as of 1993. In 1990–2015, 1.6% of new leprosy modifi cations and infl uence on leprosy control. patients were aged <15 years. -
Leprosy in Two Patients with Relapsing Remitting Multiple Sclerosis Treated with Fingolimod Alfred Balasa, M.D.1 and George J
Leprosy in Two Patients with Relapsing Remitting Multiple Sclerosis Treated with Fingolimod Alfred Balasa, M.D.1 and George J. Hutton, M.D.2 1 Department of Pediatrics, Section of Pediatric Neurology and Developmental Neuroscience; 2 Department of Neurology; Baylor College of Medicine, Houston, Texas Background A B Leprosy (Hansen’s disease) is a chronic infection caused by Mycobacterium leprae. The disease develops over months to years and may cause extensive damage to the skin and peripheral nervous system. A B In multiple sclerosis (MS), fingolimod treatment is Figure 3. Immune response in the polar clinical forms of leprosy. known to increase the risk for infections. There is one prior reported case of leprosy while on [A] In tuberculoid leprosy (TT) patients, the innate immune response is activated by M. leprae through toll-like receptors (TLR2/1). IL-15 fingolimod for relapsing remitting multiple sclerosis stimulates the vitamin D-dependent antimicrobial program in macrophages and inhibits phagocytosis of mycobacteria. These events (RRMS). We report two further cases of leprosy in promote a Th1 T-cell cytokine response (IFN-γ, IL-2, TNF, and IL-15) that contains the infection in well-formed granulomas, and a Th17 patients with RRMS and treated with fingolimod. C D response (IL-17A, IL-17F, IL-21 and IL-22) that leads to tissue inflammation and destruction, neutrophil recruitment, macrophage activation, and enhancement of Th1 effector cells. [B] In lepromatous leprosy (LL) patients, IL-4, IL-10, leukocyte immunoglobulin-like receptor subfamily A member 2 (LILRA2), and oxidized phospholipids inhibit TLR2/1-induced cytokine responses but preserve IL-10 release. -
Toman's Tuberculosis Case Detection, Treatment, and Monitoring
TOMAN’S TUBERCULOSIS TOMAN’S TUBERCULOSIS CASE DETECTION, TREATMENT, AND MONITORING The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Written by a number of experts in the field, it remains faithful to Kurt Toman’s original question-and-answer format, with subject matter grouped under the three headings Case detection, Treatment, and Monitoring. It is a testament to the enduring nature of the first edition that so much CASE DETECTION, TREA material has been retained unchanged. At the same time, the new edition has had not only to address the huge resurgence of tuber- culosis, the emergence of multidrug-resistant bacilli, and the special needs of HIV-infected individuals with tuberculosis, but also to encompass significant scientific advances. These changes in the profile of the disease and in approaches to management have inevitably prompted many new questions and answers and given a different complexion to others. Toman’s Tuberculosis remains essential reading for all who need to AND MONITORING TMENT, QUESTIONS learn more about every aspect of tuberculosis – case-finding, manage- ment, and effective control strategies. It provides invaluable support AND to anyone in the front line of the battle against this disease, from ANSWERS programme managers to policy-makers and from medical personnel to volunteer health workers. SECOND EDITION ISBN 92 4 154603 4 WORLD HEALTH ORGANIZATION WHO GENEVA Toman’s Tuberculosis Case detection, treatment, and monitoring – questions and answers SECOND EDITION Edited by T. Frieden WORLD HEALTH ORGANIZATION GENEVA 2004 WHO Library Cataloguing-in-Publication Data Toman’s tuberculosis case detection, treatment, and monitoring : questions and answers / edited by T. -
January 26, 2020 Towards a Leprosy-Free Country
China CDC Weekly Announcements Preplanned Studies The 67th World Leprosy Day Towards a Leprosy-Free — January 26, 2020 Country — China, 2011−2018 1,# 1 1 Meiwen Yu ; Peiwen Sun ; Le Wang ; Hongsheng World Leprosy Day was proposed by French Wang1; Heng Gu1; Xiangsheng Chen1 humanitarian Raoul Follereau in 1954 (1) and has been annually observed around the world on the last Sunday of each January with the aim of raising Summary global awareness and knowledge about this What is already known about this topic? ancient disease and calling attention to the fact Leprosy is a chronic infectious disease that is endemic that leprosy can be prevented, treated, and cured. in several countries. Control of leprosy has had targets Since 1988, the China Leprosy Association set by World Health Organization’s (WHO) Global initiated China Leprosy Day on the same day. Strategy 2016–2020 and by China through a national Although leprosy has been declared leprosy-control plan (2011–2020). “eliminated” as a public health problem at a global What is added by this report? level by the World Health Organization (WHO) Data from the Leprosy Management Information in 2005, around 200,000 new cases are reported System in China was analyzed and showed a national globally each year (2). In 2011, the Chinese prevalence of 0.178 per 100,000 and detection rate of Ministry of Health, together with 11 other 0.037 per 100,000 residents in 2018. In addition, all ministries, implemented the “National Strategic the main targets for 2020 have been met by 2018 Plan for Eliminating Harm of Leprosy, except for the proportion of counties or cities to reach a 2011–2020 in China”, aiming to reduce both the prevalence of less than 1/100,000 and the proportion rate of grade 2 disability (G2D) and severe adverse of children cases with grade 2 disability (G2D). -
Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?
pharmaceutics Review Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication? Luíse L. Chaves 1,2,*, Yuri Patriota 2, José L. Soares-Sobrinho 2 , Alexandre C. C. Vieira 1,3, Sofia A. Costa Lima 1,4 and Salette Reis 1,* 1 Laboratório Associado para a Química Verde, Rede de Química e Tecnologia, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal; [email protected] (A.C.C.V.); slima@ff.up.pt (S.A.C.L.) 2 Núcleo de Controle de Qualidade de Medicamentos e Correlatos, Universidade Federal de Pernambuco, Recife 50740-521, Brazil; [email protected] (Y.P.); [email protected] (J.L.S.-S.) 3 Laboratório de Tecnologia dos Medicamentos, Universidade Federal de Pernambuco, Recife 50740-521, Brazil 4 Cooperativa de Ensino Superior Politécnico e Universitário, Instituto Universitário de Ciências da Saúde, 4585-116 Gandra, Portugal * Correspondence: [email protected] (L.L.C.); shreis@ff.up.pt (S.R.) Received: 30 October 2020; Accepted: 4 December 2020; Published: 11 December 2020 Abstract: Leprosy disease remains an important public health issue as it is still endemic in several countries. Mycobacterium leprae, the causative agent of leprosy, presents tropism for cells of the reticuloendothelial and peripheral nervous system. Current multidrug therapy consists of clofazimine, dapsone and rifampicin. Despite significant improvements in leprosy treatment, in most programs, successful completion of the therapy is still sub-optimal. Drug resistance has emerged in some countries. This review discusses the status of leprosy disease worldwide, providing information regarding infectious agents, clinical manifestations, diagnosis, actual treatment and future perspectives and strategies on targets for an efficient targeted delivery therapy. -
Elisabeth Catherine Mentha Hill
The Roots of Persecution: a comparison of leprosy and madness in late medieval thought and society by Elisabeth Catherine Mentha Hill A thesis submitted in partial fulfillment of the requirements for the degree of Master of Arts in History Department of History and Classics University of Alberta © Elisabeth Catherine Mentha Hill, 2016 Abstract This thesis compares madness and leprosy in the late Middle Ages. The first two chapters explore the conceptualization of madness and leprosy, finding that both were similarly moralized and associated with sin and spiritual degeneration. The third chapter examines the leper and the mad person as social identities and finds that, although leprosy and madness, as concepts, were treated very similarly, lepers and the mad received nearly opposite social treatment. Lepers were collectively excluded and institutionalized, while the mad were assessed and treated individually, and remained within their family and community networks. The exclusionary and marginalizing treatment of lepers culminated, in 1321, in two outbreaks of persecutory violence in France and Aragon, and in lesser but more frequent expulsions through the fourteenth and fifteenth centuries. The mad were not subject to comparable, collective violence. In light of the similar moral and spiritual content of leprosy and madness as concepts, this comparison indicates that a morally condemned or stigmatized condition was not sufficient to generate persecution, or to produce a persecuted social identity. It was the structure of the concept leprosy that produced a collective social identity available to the persecuting apparatus of late medieval society, while the fluid concept of madness produced the more individual identity of the mad person, which was less susceptible to the collective actions of persecution. -
550 Leprosy in China: a History. by Angela Ki-Che Leung. New York
550 Book Reviews / T’oung Pao 96 (2011) 543-585 Leprosy in China: A History. By Angela Ki-che Leung. New York: Columbia Uni- versity Press, 2009. 373 pp. Index, bibliography, ill. Angela Leung’s new book adds a very important case study that historicizes the recent “modernist” works on the history of public health in China by Ruth Rogaski,1 Carol Benedict,2 and Kerrie Macpherson.3 Unlike the above three works, which all focus on “modernity” and have rightly been well-received, Leung presents a highly original, postcolonial history of leprosy in China, which was known in antiquity as li/lai, wind-induced skin ailments, or mafeng, “numb skin.” ese symptoms were subsequently combined during the Song dynasty into a single etiology of skin ailments , i.e., dafeng/lai. Leung’s pioneering account successfully provincializes the European narrative of leprosy and public health by presenting: 1) the longer historical memory of “leprosy” in China since antiquity; 2) the important public health changes that occurred during the Song dynasty (960-1280); and 3) how the skin illnesses we call leprosy were reconceptualized during the Ming and Qing dynasties. Leung then concludes her manuscript with two fi nal chapters that successfully parallel but revise the accounts in Rogaski, Benedict, and Macpherson. Leung describes Chinese political eff orts since the nineteenth century to develop not simply a “modern” and “Western” medical regime but a “hybrid,” Sino-Western public health system to deal with the disease. e book reveals overall the centrality of China in the history of the leprosy, and it shows how leprosy played out as a global threat, which provides lessons for dealing with AIDS, SARS, and bird viruses today. -
Epidemiological Scenario of Leprosy in a Province in China: Long Delay in Diagnosis and High Rate of Deformity
Epidemiological Scenario of Leprosy in a Province in China: Long Delay in Diagnosis and High Rate of Deformity. Ge Li Shaanxi Provincial Institute for Endemic Disease Control Qing-Ping Zhang Shaanxi Provincial Institute for Endemic Disease Control Zhao-Xing Lin Shaanxi Provincial Institute for Endemic Disease Control Ping Chen Shaanxi Provincial Institute for Endemic Disease Control Chao Li ( [email protected] ) Fourth Military Medical University https://orcid.org/0000-0002-6175-5701 Research article Keywords: Leprosy, Mycobacterium leprae, China, Epidemiology Posted Date: June 24th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-34383/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on November 25th, 2020. See the published version at https://doi.org/10.1186/s12889-020-09933-6. Page 1/11 Abstract Background: This ecological study aimed to analyze both the tendency and the characteristics of leprosy in an endemic province in the Chinese Northwest. Methods: The medical records of leprosy in the province of Shaanxi, China, 1998-2018 were collected from the leprosy management information system in China (LEPMIS). Epidemiological variables were analyzed in this study. Results: 477 new cases were diagnosed between 1998-2018 in this area. The average rate of annual detection was 0.070/100,000, and the average annual prevalence was 0.305/100,000. The mean age of new patients was 46.71 years, and the ratio of male to female was 2.46:1. There were 399 cases (83.6%) of multibacillary (MB) forms.